Quarterly report pursuant to Section 13 or 15(d)

Significant Transactions (Tables)

v3.24.1.1.u2
Significant Transactions (Tables)
9 Months Ended
Mar. 31, 2024
Summary of Purchase Price Allocation of Asset Acquisition

Preferred stock

$

1,760,000

Intangible assets

4,300,000

Prepaid expenses

1,440,000

$

7,500,000

RubrYc Therapeutics Inc [Member] | Asset Purchase Agreement [Member]  
Summary of Purchase Price Allocation of Asset Acquisition

Intangible assets

$

1,228,000

Fixed assets

114,000

$

1,342,000